• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by PACS Group Inc.

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    SC 13G 1 pacs-markhancock13g11_2024.htm SC 13G Document

    Securities and Exchange Commission
    Washington, D.C. 20549
    Schedule 13G
    (Rule 13d-102)
    Information to be Included in Statements Filed Pursuant
    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed
    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. )*

    PACS Group, Inc.
    (Name of Issuer)

    Common Stock
    (Title of Class of Securities)
    69380Q107
    (CUSIP Number)
    September 30, 2024
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [ ]    Rule 13d-1(b)
    [ ]    Rule 13d-1(c)
    [X]    Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



    CUSIP No. 69380Q107
    Schedule 13G
    Page 1 of 4

        1
    Names of Reporting Persons

    Mark Hancock
        2
    Check the Appropriate Box if a Member of a Group

    (a) [X] (b) [ ]
        3
    SEC Use Only

        4
    Citizenship or Place of Organization

    United States
    Number of Shares Beneficially Owned by Each Reporting Person With
    5
    Sole Voting Power
    54,626,199
    6
    Shared Voting Power
    0
    7
    Sole Dispositive Power
    54,626,199
    8
    Shared Dispositive Power
     
    0
        9
    Aggregate Amount Beneficially Owned by Each Reporting Person

        54,626,199
        10
    Check if the Aggregate Amount in Row (9) Excludes Certain Shares

        
    Not Applicable
        11
    Percent of Class Represented by Amount in Row 9

        
    35.2%
        12
    Type of Reporting Person

        
    IN




    CUSIP No. 69380Q107
    Schedule 13G
    Page 2 of 4

    ITEM 1.(a)    Name of Issuer:
    PACS Group, Inc. (the “Issuer”).
    (b)Address of Issuer’s Principal Executive Offices:

    262 N. University Ave., Farmington, Utah 84025.
    ITEM 2.(a)    Name of Person Filing:
    This statement is filed on behalf of Mark Hancock (the “Reporting Person”).
    (b)Address or Principal Business Office:
    The business address of the Reporting Person is c/o PACS Group, Inc., 262 N. University Ave., Farmington, Utah 84025.
    (c)Citizenship:

    The Reporting Person is a citizen of the United States of America.

    (d)Title of Class of Securities:

    Common stock, par value $0.001 per share (“Common Stock”).
    (e)CUSIP Number:

    69380Q107
    ITEM 3.
    Not applicable.
    ITEM 4.Ownership.

        The ownership information below represents beneficial ownership of shares of Common Stock as of September 30, 2024, based upon 155,177,511 shares of Common Stock outstanding as of September 9, 2024.
    (a) Amount beneficially owned:
    The Reporting Person is the record holder of 45,126,199 shares of Common Stock and the beneficial owner of 9,500,000 shares of Common Stock held in Cougar 2, LLC, a limited liability company of which he is the sole owner.



    CUSIP No. 69380Q107
    Schedule 13G
    Page 3 of 4

    (b) Percent of class: 35.2%
    (c) Number of shares as to which the person has:
    (i)Sole power to vote or to direct the vote: 54,626,199
    (ii)Shared power to vote or direct the vote: 0
    (iii)Sole power to dispose or to direct the disposition of: 54,626,199
    (iv)Shared power to dispose or to direct the disposition of: 0
    ITEM 5.Ownership of Five Percent or Less of a Class.
        Not applicable.
    ITEM 6.Ownership of More than Five Percent on Behalf of Another Person.
    The Reporting Person and Jason Murray are parties to a Stockholders Agreement (the “Stockholders Agreement”), which contains, among other things, certain provisions relating to transfer of, and coordination of the voting of, securities of the Issuer by the parties thereto.
    By virtue of the Stockholders Agreement and the obligations and rights thereunder, the Reporting Person acknowledges and agrees that he is acting as a “group” with Mr. Murray within the meaning of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Reporting Person expressly disclaims beneficial ownership over any shares of Common Stock that he may be deemed to beneficially own solely by reason of the Stockholders Agreement. Mr. Murray is separately filing a Schedule 13G reporting his beneficial ownership of the Common Stock.
    ITEM 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
    Not applicable.
    ITEM 8.Identification and Classification of Members of the Group.

    Not applicable.
    ITEM 9.Notice of Dissolution of Group.
    Not applicable.
    ITEM 10. Certification.
    Not applicable.



    CUSIP No. 69380Q107
    Schedule 13G
    Page 4 of 4

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:    November 14, 2024

    Mark Hancock

    /s/ Mark Hancock            



    Get the next $PACS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PACS Group downgraded by Analyst with a new price target

    Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

    12/17/24 8:16:05 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    JP Morgan resumed coverage on PACS Group with a new price target

    JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

    11/6/24 6:27:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    UBS initiated coverage on PACS Group with a new price target

    UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00

    10/9/24 7:56:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    SEC Filings

    View All

    SEC Form S-8 filed by PACS Group Inc.

    S-8 - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:07:14 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:06:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by PACS Group Inc.

    10-Q - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:05:41 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), on September 10, 2025, announced that on September 9, 2025, the New York Stock Exchange ("NYSE") Listing Operations Committee agreed to provide the Company with an additional trading period through November 19, 2025, subject to its ongoing review of the Company. The additional trading period provides PACS additional time to complete the previously announced restatement of its financial statements for the three months ended March 31, 2024, and the three and six months ended June 30, 2024 and become current with its SEC filing obligations, which are required for the Company to regain compliance with the NYSE listing standards. "We have

    9/11/25 8:17:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 16,777 shares, decreasing direct ownership by 5% to 326,591 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:32:30 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Compliance Officer Lee Joseph Robert covered exercise/tax liability with 28,763 shares, decreasing direct ownership by 4% to 648,122 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:31:48 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Officer Sanford Peter covered exercise/tax liability with 72,924 shares, decreasing direct ownership by 5% to 1,280,872 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:31:05 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Financials

    Live finance-specific insights

    View All

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Provides Preliminary Third Quarter Operational Metrics

    Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op

    11/6/24 6:00:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care